Rao, Ling http://orcid.org/0000-0002-2519-8848
Mak, Victor C. Y.
Zhou, Yuan
Zhang, Dong
Li, Xinran
Fung, Chloe C. Y.
Sharma, Rakesh
Gu, Chao
Lu, Yiling
Tipoe, George L.
Cheung, Annie N. Y.
Mills, Gordon B. http://orcid.org/0000-0002-0144-9614
Cheung, Lydia W. T. http://orcid.org/0000-0003-1137-3200
Article History
Received: 29 July 2019
Accepted: 9 April 2020
First Online: 8 May 2020
Competing interests
: G.B.M. consults with AstraZeneca, ImmunoMET, Ionis, Nuevolution, PDX bio, Signalchem, Symphogen, and Tarveda; has stock options with Catena Pharmaceuticals, ImmunoMet, SignalChem, Spindle Top Ventures, and Tarveda; sponsored research from AstraZeneca, Immunomet, Pfizer, Nanostring, and Tesaro; travel support from Chrysallis Bio; and has licensed technology to Nanostring and Myriad Genetics. The other authors declare no competing interests.